|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/22 | (2006.01) |
| G01N 33/74 | (2013.01) | ||
| C07K 14/72 | (2006.01) | ||
| G01N2800/52 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| G01N 33/567 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| G01N 33/74 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 5/24 | (2018.01) |
| (11) | Number of the document | 3509624 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17849795.4 |
| Date of filing the European patent application | 2017-09-12 | |
| (97) | Date of publication of the European application | 2019-07-17 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/051232 |
| Date | 2017-09-12 |
| (87) | Number | WO 2018/049424 |
| Date | 2018-03-15 |
| (30) | Number | Date | Country code |
| 201662393632 P | 2016-09-12 | US |
| (72) |
SAILSTAD, Jeffrey , US
|
| (73) |
Amryt Pharmaceuticals Inc. ,
160 Federal Street 21st Floor, Boston, MA 02110,
US
|
| (54) | METHODS OF DETECTING ANTI-LEPTIN NEUTRALIZING ANTIBODIES |
| METHODS OF DETECTING ANTI-LEPTIN NEUTRALIZING ANTIBODIES |